Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts.
Pediatric glioblastomas (pGBM), although rare, are one of the leading causes of cancer-related deaths in children, with tumors essentially refractory to existing treatments. Here, we describe the use of conventional and advanced in vivo magnetic resonance imaging (MRI) techniques to assess a novel o...
Main Authors: | Patricia Coutinho de Souza, Samantha Mallory, Nataliya Smith, Debra Saunders, Xiao-Nan Li, Rene Y McNall-Knapp, Kar-Ming Fung, Rheal A Towner |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4527837?pdf=render |
Similar Items
-
OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth
by: Rheal A. Towner, et al.
Published: (2019-02-01) -
OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma
by: Lincy Thomas, et al.
Published: (2020-11-01) -
Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model
by: Michelle Zalles, et al.
Published: (2020-03-01) -
Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ
by: Kyeung Min Joo, et al.
Published: (2013-01-01) -
Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy
by: Michele Patrizii, et al.
Published: (2018-02-01)